Mr. Chien Huang reports
TITAN ANNOUNCES Q&A SESSION WITH SHAREHOLDERS
Titan Medical Inc. will host a webcast on Thursday, Sept. 19, 2024, at 5 p.m. ET in connection with filing and mailing of the management information circular, which was confirmed by a press release issued on Sept. 6, 2024. Titan will provide prepared remarks, followed by a question-and-answer session. Paul Cataford, interim president and chief executive officer, and Chien Huang, chief financial officer, will attend the session on behalf of Titan.
Shareholders are invited to submit questions in advance of the Q&A session to
investors@titanmedicalinc.com. Questions will be accepted until Sept. 17, 2024, at 1 p.m. ET. A link to the live audio webcast will be made available on the company's website.
About Titan Medical Inc.
Titan Medical, a medical technology company incorporated under the Business Corporations Act (Ontario) and headquartered in Toronto, Ont., has developed an expansive patent portfolio related to the enhancement of robotic assisted surgery (RAS), including through a single access point, and is currently focused on evaluating new opportunities to further develop and license its intellectual property.
We seek Safe Harbor.
© 2025 Canjex Publishing Ltd. All rights reserved.